Testing blood lithium levels in people with depression and suicidality
Treatments studied
Part of Mental health clinical trials.
This study checks how much lithium is naturally present in the blood and whether that relates to suicidal thoughts or attempts in people with a current major depressive episode. It may help researchers understand biological factors linked to suicide risk and improve future prevention.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- You currently have a major depressive episode (a significant period of depression that meets DSM-5 criteria)
- You have not taken lithium medicines in the past 12 months
- If you are in the suicide group: you had a suicidal event (thoughts or attempt) in the past 12 months
- If you are in the comparison group: you have had no suicidal event in the past 12 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at tiny blood particles (exosomes) and specific microRNAs to see if they can signal suicide risk and predict treatment outcomes in adolescents. If you qualify, your blood may be used to help researchers find better ways to understand and track suicidality and depression treatment response.
This study checks whether tiny genetic signals in blood (microRNAs) are linked to childhood maltreatment and thoughts or risk of suicide, especially in people with major depression. It may help researchers understand biological clues that could someday guide better care.
This study tests a new blood test (EDIT-B®) to help doctors tell the difference between depression and bipolar disorder. If you have a depressive episode but there is doubt about bipolar disorder, this test might help guide your treatment to improve your health.
This study looks at how depression, bipolar disorder, and suicide risk naturally change over time. It aims to better understand these conditions so doctors can improve treatments.
This study looks for early warning signs—both mood symptoms and physical/behavior changes—that can help predict unipolar (non-manic) depression in people receiving outpatient care. It may help researchers develop better ways to recognize who is at risk and track symptoms over time.
This trial tests a new medical device that uses a blood test to help doctors accurately diagnose bipolar disorder in people who were thought to have major depression. It aims to see if the device can tell the difference and improve treatment choices.
Hear when a new Major Depressive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.